栓塞化疗合并注射无水乙醇治疗原发性肝癌(附112例报告)

目的探讨栓塞化疗合并瘤内注射无水乙醇治疗原发性肝癌（简称肝癌）的疗效。方法回顾性分析采用动脉插管栓塞化疗（TACE）与经皮注射无水乙醇（PEI）序贯治疗112例肝癌患者（研究组），并与同期病例相似的70例肝癌（对照组）单纯采用TACE治疗的疗效相比较。结果首次治疗后AFP下降有效率（CR＋PR）：研究组为68．8％，对照组为30．0％；肿瘤体积缩小率（CR＋PR）：研究组为78．6％，对照组为34．3％。第2疗程川1P下降有效率（CR＋PR）：研究组为77．8％，对照组为28％；肿瘤体积缩小率（CR＋PR）：研究组为80．5％，对照组为45．0％。以上两组间差异均有统计学意义（P均〈0．05）。结论TACE合并PEI治疗肝癌可以提高疗效，是合理有效的治疗方法。

Treatment of combined trans-arterial chemoenbolization and percutaneous ethanol injection for hepatocellular carcinoma- a report of 112 cases

Objective To investigate the efficacy of treatment of combined trans-arterial chemoembolizatin and percutaneous ethanol injection for hepatocarcinoma.Methods A retrospective analysis of 112 cases with hepatocarcinoma (studied group) received the sequent treatment of combined trans-arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI),and comparing with 70 cases with hepatocarcinoma (control group) that received TACE only.Results After treating for the first time,with level of AFP declined,(CR+PR) rate of the studied group was 68.8% and that of control grouup was 30.0%,and the reduction in tumor size (CR+PR) of the studied group was 78.6% and that of control group was 34.3%.After second time treating ,with level of AFP declined,(CR+PR) rate was 77.8% in the studied group and 28.0% in control group,and the reduction in tumor size (CR+PR) was 80.5% in the studied group and 45.0% in control group.Conclusion TACE and PEI sequent therapy is an effective treatment for hepatocarcinoma.